Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
7.27
-0.79 (-9.80%)
At close: Oct 30, 2026, 4:00 PM EDT
7.31
+0.04 (0.55%)
After-hours: Oct 30, 2026, 7:45 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Alignment Healthcare stock has a consensus rating of "Buy" and an average price target of $11.96. The average 1-year stock price forecast is 64.51% higher than the current stock price, while the lowest is $8.00 (+10.04%) and the highest is $26 (+257.63%).
Price Target: $11.96 (+64.51%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 9 | 9 | 6 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +10.04% | Oct 30, 2026 |
| UBS | UBS | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +10.04% | Oct 30, 2026 |
Unknown Analyst Stephens No rating | Stephens | Buy Maintains $10 | Buy | Maintains | $10 | +37.55% | Oct 30, 2026 |
| Barclays | Barclays | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +23.80% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
5.22B
from 3.95B
Increased by 32.12%
Revenue Next Year
6.56B
from 5.22B
Increased by 25.65%
EPS This Year
0.45
from 0.32
Increased by 40.78%
EPS Next Year
0.65
from 0.45
Increased by 43.65%
EPS and Forward PE are based on non-GAAP adjusted numbers.